
|Articles|August 20, 2012
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
Advertisement
This content is provided by Amgen.
Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.
Please click the image below to view the presentation.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
2
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
3
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
4
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
5















































